Cervical/Uterine Cancers Panel - Disclosures
|
Panel Member
|
Nadeem Abu-Rustum MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Sudha Amarnath MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Rebecca Arend MD |
|
Grant/Research Support
|
| AbbVie, Inc. | Artera | Champions Oncology, Inc. | Exelixis Inc. | Faeth therapeutics | GSK | ImmunoGen, Inc. | Leap Therapeutics | lifenet | Merck & Co., Inc. | Regeneron Pharmactcls |
|
Date Completed
|
11/22/2024 |
|
Panel Member
|
Emma Barber MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Marian Birkeland PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nicole Blankenhorn |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kristin Bradley MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Rebecca Brooks MD |
|
Product/Speakers Bureau
|
| AstraZeneca Pharmaceuticals LP | GSK |
|
Date Completed
|
03/28/2025 |
|
Panel Member
|
Susana Campos MD, MPH, MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Junzo Chino MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Hye Sook Chon MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Marta Ann Crispens MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Shari Damast MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Christine Fisher MD, MPH |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Peter Frederick MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
David Gaffney MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Stephanie Gaillard MD, PhD |
|
Grant/Research Support
|
| AstraZeneca Pharmaceuticals LP | BeiGene | Blueprint Medicines | Clovis Oncology | Compugen | Genentech, Inc. | ImmunoGen, Inc. | MDAnderson | Tempest | TESARO, Inc. | Volastra |
|
Royalty Income
|
| UpToDate |
|
Date Completed
|
07/30/2024 |
|
Panel Member
|
Robert Giuntoli II MD |
|
Grant/Research Support
|
| AstraZeneca Pharmaceuticals LP |
|
Date Completed
|
11/05/2024 |
|
Panel Member
|
Scott Glaser MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kristina Gregory MSN, RN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Erin Hesler |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Brooke Howitt MD |
|
Equity Interest/Stock Options
|
| Cartography | Santa Ana Bio |
|
Date Completed
|
07/30/2024 |
|
Panel Member
|
Kari Kendra MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Lisa Landrum MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jayanthi Lea MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nita Lee MD, MPH |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Gina Mantia-Smaldone MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Andrea Mariani MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nicole McMillian MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
David Mutch MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Christa Nagel MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Larissa Nekhlyudov MD, MPH |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Chika Nwachukwu MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Aaron Oliver PharmD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Sharon Park PharmD, BCOP |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Mirna Podoll MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Donna Powell DHSc, CMD, RT(T) |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kerry Rodabaugh MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Ritu Salani MD, MBA |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Vaishnavi Sambandam PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
John Schorge MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Scott Schuetze MD, PhD |
|
Grant/Research Support
|
| Adaptimmune | Boehringer Ingelheim GmbH | Shanghai Pharma Biotherapeutics | TRACON Pharmaceuticals, Inc. |
|
Date Completed
|
08/16/2024 |
|
Panel Member
|
Jean Siedel DO, MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Pamela Soliman MD, MPH |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Stefanie Ueda MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Renata Urban MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Erin Vidic |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Amanda Visnick BSN, RN, OCN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Emily Wyse |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
